# GORE® Septal Occluder European Union Clinical Evaluation

> **NCT01605851** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 150 (actual)

## Conditions studied

- Closure; Foramen Ovale

## Interventions

- **DEVICE:** Closure, Foramen Ovale

## Key facts

- **NCT ID:** NCT01605851
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605851, "GORE® Septal Occluder European Union Clinical Evaluation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01605851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*